Literature DB >> 9270056

The expression of creatine kinase isoenzymes in neocortex of patients with neurodegenerative disorders: Alzheimer's and Pick's disease.

M Y Aksenov1, M V Aksenova, R M Payne, C D Smith, W R Markesbery, J M Carney.   

Abstract

Creatine kinase (CK) activity was found decreased in the brains of patients with Alzheimer's disease (AD) and Pick's disease (PD). However, the decrease of total CK activity in AD was more pronounced than in PD. Analysis of the activity of two CK isoforms, BCK and ubiquitous mitochondrial CK, demonstrated that the decrease of total CK activity in AD and PD was related to the decrease of BCK activity. The decline of CK activity both in AD and PD correlated well with the decline of the content of immunoreactive BCK in brain extracts. The BCK mRNA level in AD and PD was not significantly different from control patients and could not be the primary reason for decreases in CK content and activity. The decreased level of BCK in AD and PD brains might be caused by posttranscriptional events, which could affect the translation of BCK mRNA and/or lead to the inactivation and degradation of the enzyme. Because CK is sensitive to oxidative modification, it is possible that the changes observed in this study result from free radical damage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9270056     DOI: 10.1006/exnr.1997.6550

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  26 in total

1.  Crystal structure of brain-type creatine kinase at 1.41 A resolution.

Authors:  M Eder; U Schlattner; A Becker; T Wallimann; W Kabsch; K Fritz-Wolf
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

2.  Creatine and antioxidant treatment prevent the inhibition of creatine kinase activity and the morphological alterations of C6 glioma cells induced by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.

Authors:  Cláudia Funchal; Patrícia Fernanda Schuck; André Quincozes Dos Santos; Maria Caroline Jacques-Silva; Carmem Gottfried; Regina Pessoa-Pureur; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2006-02       Impact factor: 5.046

Review 3.  Energy dysfunction in Huntington's disease: insights from PGC-1α, AMPK, and CKB.

Authors:  Tz-Chuen Ju; Yow-Sien Lin; Yijuang Chern
Journal:  Cell Mol Life Sci       Date:  2012-05-25       Impact factor: 9.261

4.  Identification of mouse brain proteins associated with isoform 3 of metallothionein.

Authors:  David W Lahti; John D Hoekman; Abigail M Tokheim; Bruce L Martin; Ian M Armitage
Journal:  Protein Sci       Date:  2005-03-31       Impact factor: 6.725

5.  Effect of histidine administration to female rats during pregnancy and lactation on enzymes activity of phosphoryltransfer network in cerebral cortex and hippocampus of the offspring.

Authors:  Denise Bertin Rojas; Rodrigo Binkowski de Andrade; Tanise Gemelli; Lenise Santos Oliveira; Aline Guimarães Campos; Carlos Severo Dutra-Filho; Clóvis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2012-05-27       Impact factor: 3.584

6.  Proline reduces creatine kinase activity in the brain cortex of rats.

Authors:  Adriana Kessler; Elisa Costabeber; Carlos Severo Dutra-Filho; Angela Terezinha Souza Wyse; Moacir Wajner; Clóvis Milton Duval Wannmacher
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

7.  First evidence of overlaps between HIV-Associated Dementia (HAD) and non-viral neurodegenerative diseases: proteomic analysis of the frontal cortex from HIV+ patients with and without dementia.

Authors:  Li Zhou; Eve Diefenbach; Ben Crossett; Sieu L Tran; Thomas Ng; Helen Rizos; Rejane Rua; Bin Wang; Amit Kapur; Kaushal Gandhi; Bruce J Brew; Nitin K Saksena
Journal:  Mol Neurodegener       Date:  2010-06-24       Impact factor: 14.195

8.  Inhibition of mitochondrial creatine kinase activity by D-2-hydroxyglutaric acid in cerebellum of young rats.

Authors:  Cleide G da Silva; Ana Rubia F Bueno; Rafael B Rosa; Carlos S Dutra Filho; Clovis M D Wannmacher; Angela T S Wyse; Moacir Wajner
Journal:  Neurochem Res       Date:  2003-09       Impact factor: 3.996

Review 9.  Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.

Authors:  D Allan Butterfield; Tanea Reed; Shelley F Newman; Rukhsana Sultana
Journal:  Free Radic Biol Med       Date:  2007-06-13       Impact factor: 7.376

10.  Amyloid beta-peptide (1-40)-mediated oxidative stress in cultured hippocampal neurons. Protein carbonyl formation, CK BB expression, and the level of Cu, Zn, and Mn SOD mRNA.

Authors:  M Y Aksenov; M V Aksenova; W R Markesbery; D A Butterfield
Journal:  J Mol Neurosci       Date:  1998-06       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.